[O13] Oral Session 13"Cancer 2"

[O13-7] Combination therapy of immunostimulatory CVB3 and PD-L1 blockade works to enhance anti-tumor efficacy

^○Miyako Sagara¹, Shohei Miyamoto², Shun Ito¹, Yasushi Soda¹, Tetsu Akiyama¹, Mutsunori Murahashi², Kenzaburo Tani¹ (1.The University of Tokyo, 2.The Jikei University Scool of Medicine)